(Q37786496)

23 August 2017

title

Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL (English)

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

9 July 2024

author name string

Prediman K. Shah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20827180

9 July 2024

language of work or name

1 reference

1 November 2010

1 reference

full work available at URL

23 August 2017

https://journals.lww.com/10.1097/HCO.0b013e32833f0382

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Current Opinion in Cardiology

9 July 2024

published in

1 reference

23 August 2017

volume

25

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

603-608

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

9 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.

9 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Emerging HDL-based therapies for atherothrombotic vascular disease

9 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Future therapeutic directions in reverse cholesterol transport

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

High-density lipoprotein heterogeneity and function in reverse cholesterol transport

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.

9 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor

9 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

High-density lipoprotein reduces the human monocyte inflammatory response

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity

9 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques

9 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Inflammation impairs reverse cholesterol transport in vivo.

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Protective roles of HDL, apoA-I and mimetic peptide on endothelial function: through endothelial cells and endothelial progenitor cells

9 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins

9 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

The role of dysfunctional HDL in atherosclerosis

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

The HDL proteome: a marker--and perhaps mediator--of coronary artery disease

9 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials

9 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Niacin: an old drug rejuvenated

9 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

The yin and yang of cholesteryl ester transfer protein in cardiovascular disease

9 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Effects of torcetrapib in patients at high risk for coronary events

9 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Effect of torcetrapib on the progression of coronary atherosclerosis

9 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

9 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

9 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib

9 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo

9 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome

9 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Biological properties of apolipoprotein a-I mimetic peptides

9 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

9 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

9 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

9 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice

9 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages

9 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

9 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

9 July 2024

41

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

A novel endothelial-derived lipase that modulates HDL metabolism

9 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans

9 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors

9 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

Gene therapy to improve high-density lipoprotein metabolism and function

9 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/HCO.0B013E32833F0382

9 July 2024

Identifiers

1 reference

23 August 2017

1 reference